Exploratory Study Evaluating the Relevance of [68Ga]Ga-FAPI-46 for Staging and Identifying Progressing Patients With Transthyretin Cardiac Amyloidosis
NCT07549841
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Transthyretin Cardiac Amyloidosis
Interventions
DRUG:
[68Ga]Ga-FAPI-46
Sponsor
Nantes University Hospital